Abiopharma

🔍 Indig Chaim (Director)

Company: Phreesia, Inc. (PHR)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Acquired 21,870 shares of Common Stock at $4.71 per share (Direct)
  Date: 2025-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,273,273.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 70,377 shares of Common Stock at $8.03 per share (Direct)
  Date: 2025-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,343,650.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 92,247 shares of Common Stock at $32.0166 per share (Direct)
  Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,251,403.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,746 shares of Common Stock at $32.4653 per share (Direct)
  Date: 2025-08-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,251,403.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 5,913 shares of Common Stock at $8.03 per share (Direct)
  Date: 2025-08-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,259,149.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,833 shares of Common Stock at $4.71 per share (Direct)
  Date: 2025-08-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,253,236.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: Indig Dynasty Trust | shares_owned_after: 255,000.00 | Footnotes: F4
• Sold 70,377 shares of Stock Options (Right to Buy) at $8.03 per share (Derivative)
  Date: 2025-08-27 | Code: M | Expires: 2029-01-16 | equity_swap_involved: 0 | shares_owned_after: 395,432.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 21,870 shares of Stock Option (Right to Buy) at $4.71 per share (Derivative)
  Date: 2025-08-27 | Code: M | Expires: 2028-01-30 | equity_swap_involved: 0 | shares_owned_after: 1,833.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 5,913 shares of Stock Options (Right to Buy) at $8.03 per share (Derivative)
  Date: 2025-08-28 | Code: M | Expires: 2029-01-16 | equity_swap_involved: 0 | shares_owned_after: 389,519.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,833 shares of Stock Option (Right to Buy) at $4.71 per share (Derivative)
  Date: 2025-08-28 | Code: M | Expires: 2028-01-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 19, 2024.
• F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: These shares are held by a family trust of which the reporting person's sister-in-law is the investment advisor and distribution advisor. Members of the reporting person's immediate family are the sole beneficiaries of such trust.
• F5: This option is fully vested and exercisable as of the date hereof.